Finally, baseline WAT mRNA expressions of NLRP3 or IL1B were associated with systemic risk factors for T2D and markers of WAT inflammation and dysfunction without a group-difference (Supplementary Fig S5). The gene discussed is NLRP3; the disease is type 2 diabetes mellitus.